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Abstract
Fetal chromosomal abnormalities are the most common reasons for invasive prenatal testing. Currently, G-band karyotyping
and several molecular genetic methods have been established for diagnosis of chromosomal abnormalities. Although these
testing methods are highly reliable, the major limitation remains restricted resolutions or can only achieve limited coverage
on the human genome at one time. The massively parallel sequencing (MPS) technologies which can reach single base pair
resolution allows detection of genome-wide intragenic deletions and duplication challenging karyotyping and microarrays
as the tool for prenatal diagnosis. Here we reported a novel and robust MPS-based method to detect aneuploidy and
imbalanced chromosomal arrangements in amniotic fluid (AF) samples. We sequenced 62 AF samples on Illumina GAIIx
platform and with averagely 0.016whole genome sequencing data we detected 13 samples with numerical chromosomal
abnormalities by z-test. With up to 26 whole genome sequencing data we were able to detect microdeletion/
microduplication (ranged from 1.4 Mb to 37.3 Mb of 5 samples from chorionic villus sampling (CVS) using SeqSeq
algorithm. Our work demonstrated MPS is a robust and accurate approach to detect aneuploidy and imbalanced
chromosomal arrangements in prenatal samples.
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Introduction
Chromosomal abnormalities occur in 1 of 160 live births [1].The
risk of giving birth to a child with chromosomal abnormalities,
especially Down syndrome (OMIM# 190685), increases through-
out a woman’s reproductive years [2,3]. Prenatal diagnosis of fetal
chromosomal abnormalities is the most common indication for
invasive prenatal testing. The prevalence of chromosomal abnor-
malities in fetuses with aneuploidy accounts for 6–11% of all
stillbirths and neonatal deaths [4,5]. Consequently, screening and
diagnostic programs to detect the most common trisomies in live
born infants arewell established[6].Currently,G-bandkaryotyping
and several molecular genetic methods including multiplex ligation-
dependent probe amplification (MLPA), fluorescence in situ
hybridization (FISH), quantitative fluorescent PCR (QF-PCR)
and microarray-based comparative genomic hybridization (ar-
rayCGH) have been well established for prenatal diagnosis of
chromosomal abnormalities in clinical labs [7,8]. Although these
testing methods have been proved to be highly reliable, the major
limitation remains restricted resolution or can only achieve limited
coverage on the human genome at one time [9,10].
To overcome these limitations, in this study we have developed
a new method based on massively parallel sequencing (MPS)
platform to detect fetal chromosomal abnormalities, which is
independent of particular genetic markers and cell culture in
medical practice. We directly sequenced 62 DNA samples
extracted from uncultured amniotic fluid (AF) of pregnant women.
After statistical analysis, we can clearly detect numerical
chromosomal abnormalities among 46 chromosomes. The whole
process only takes 7 days and the results were validated by full
karyotyping analysis. Subsequently, we investigated the presence
of copy number variations among 5 prenatal samples previously
identified by arrayCGH. We demonstrated that with different
whole genome sequencing coverage MPS platform could be
applied for identification of aneuploidy and imbalanced chromo-
somal arrangements, and those approaches are more sensitive and
effective compared with conventional methods.
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Detection of Fetal Aneuploidy
In this study, the 32 test cases were used for sequencing analysis
under double-blind conditions. For all 62 AF samples (30 normal
controls and 32 test cases), we obtained 0.55,3.28 million 35-bp
single-end reads (or 19.25 Mb,114.80 Mb sequencing data)
which corresponds to 0.006,0.0386 human genome depth.
Consequently, 0.20,1.15 million unique reads (UR) were
obtained for each sample (Table 1). For each chromosome, the
number of unique reads was counted and the UR% was
calculated. The complete set of UR% for 62 samples is listed in
Table S1. UR% for Chromosome X, Y also showed in Fig. 1. The
gender of each sample can be determined from UR% of
Chromosome X, Y. For 30 normal control samples, the mean
and standard deviation (SD) of UR% for each chromosome were
calculated. Then the z-scores of each of the chromosomes, except
the Y chromosome, for each of the normal controls and test cases
were calculated according to the formula described in Materials and
methods (Table S2). From 32 test cases, 5 cases had a z-score.20
for chromosome 18 (indicating Trisomy 18), 6 cases had a z-
score.20 for chromosome 21 (indicating Trisomy 21), and 2 cases
had a z-scorer20 for chromosome X (indicating XO). All the
other chromosomes had z-scores within 63 for all 32 test cases
(indicating euploid chromosomes) (Fig. 2, Table. S1). The
detection of fetal aneuploidy based on sequencing analysis agreed
with karyotyping results.
NormalizedUR%valuesforall22autosomesandchromosomeX
were calculated (Fig. 3). 5 cases of trisomy 18, 6 cases of trisomy 21
and 2 cases of XO were successfully detected in the cohort of 32 test
cases, which presented 100% of sensitivity and 100% of specificity.
Detection of imbalanced chromosomal arrangements
To further validated our developed and optimized analysis
method among cases with imbalanced chromosomal arrange-
ments, we obtained 44,70 M sequence tags for the 5 ‘‘known’’
samples with 1.4 to 2.36 whole genome depth. To detect
segmental copy number variations, a sequence-based Matlab
CNV detection package, SegSeq, with YH reference genome as
comparative genome were used. By applying the SegSeq analysis,
we detected microdeletions and microduplications in all 5 samples
(Table 2). All the 5 chromosomal copy number variations ranged
from 1.4 Mb to 37.3 Mb were validated by arrayCGH and were
mapped precisely to the correct location. Four pregnancies were
terminated after genetic detection and only one pregnant gave a
live birth (Table S3).
Two samples (A10021383, A10071659) were selected to further
ascertain the results on the HumanOmni2.5 M chip (Illumina).
CNV partition Algorithm plug-in, was used to detect copy number
variations in these two samples. A duplication at 2q36,q37.3
(230369496,242444380) and a deletion at 13q32.3q33.3
(97091318,106462788) were correctly detected, totally in con-
cordance with the arrayCGH and sequencing analysis results.
Discussion
Massively parallel sequencing has been reported only to apply in
noninvasive prenatal diagnosis of trisomy 21, 18 and 13 based on
cell-free fetal DNA, due to it is limited amount of fragmented fetal
DNA [11]. This also makes noninvasive MPS-based prenatal
diagnosis difficult to detect all the chromosomal aneuploidies and
the sexual chromosome abnormality accurately. In this study, we
demonstrated for the first time that combined MPS with powerful
bioinformatics analysis method can accurately diagnosis fetal
aneuploidy and imbalanced chromosomal structural abnormali-
ties. In fact, this study reports the first retrospective use of MPS (so
called next generation sequencing) for prenatal diagnostics of
chromosomal imbalance rearrangements to date and shows that it
is practically feasible on a large-scale prenatal diagnosis of fetal
chromosomal abnormalities.
By establishing a normal control sequencing tag data set, we
have been able to demonstrate this new approach only requires a
minimum among of DNA materials (100 ng) to achieve the
identification of aneuploidies with a ultra low sequencing coverage
(0.016). Comparing to the golden standard (G-Band karyotyping)
in clinical practice, MPS has no time limitation. Also as long as
100 ng genomic DNA can be extracted from tissues at any
gestational weeks, MPS can be performed and report all fetal
aneuploidies in 7 days. If necessary, more sequence reads can be
performed to detect whether microdeletion or microduplication
exists in the fetal genome which may result in severe develop-
mental retardation. In our study, tissues obtained from fetus, such
as amniotic fluid, CVS and placenta can be analyzed without cell
culture since 100 ng genomic DNA is sufficient for library
preparation and sequencing. So it can be used for the research
into the molecular mechanism of miscarriage, stillbirth and fetal
death when tissues are difficult to culture. Furthermore, our
validation study on the 5 arrayCGH samples show that when
more sophisticated sequencing protocols and bioinformatics
algorithms are applied to the analysis, it is possible to detect
smaller size chromosomal copy number variations as well as
complex rearrangements across the whole genome of the fetus,
such as balanced chromosomal arrangements,structure variations
or even single-gene disorders. With the application of third-
generation sequencing system in clinical laboratories, such as
Miseq/Illumina and Ion Torrent PGM/Life Technologies, the
whole process will take less time and acceptable price. Thus, it is
likely that MPS will play an increasingly important role in the
future development of prenatal screening and diagnosis.
A potential weakness of the study was that in the figure of
describing the ratio of unique reads in each chromosome,
chromosome19 and 22 have a differently huge coefficient of
variation because of their extremely high GC content and made
the detection of trisomy19 and trisomy22 difficult. Further study
will be set up to deal with these problems, for example the
computational correction of GC content among chromosomes.
Other chromosomal abnormalities, such as balanced translocation
or incomplete aneuploidy caused by mosaics or partial duplication
or deletion of a chromosome should, in principle, also be
detectable. Further studies are required to determine the
effectiveness of massively parallel genomic sequencing in detecting
these rare aberrations. Another weakness for the new methodology
was the starting materials for library construction; with the
conventional Illumina library construction approach100 ng geno-
mic DNA of fetus was required. To further reduce the risk to
pregnancies it would be important to reduce the amount for AF or
CVS samples, other library construction methods such as using in
vitro transposition may be an alternative solution.
In conclusion, we have demonstrated the usefulness of massively
parallel sequencing to detect fetal aneuploidy and imbalanced
chromosomal abnormalities of genomic DNA in prenatal samples.
In principle, massively parallel sequencing can also reveal other
features of the genomic material from amniotic fluid such as
histone modifications as well as epigenetic DNA methylation. With
the rapid reduction of sequencing cost, we expect that the strategy
described in this article will become a powerful tool in the
detection of all kinds of chromosomal abnormalities in clinical
settings.
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Sample
No.
Labrary
No.
Fetal
Karyotype
DNA Amount
(ng)
Raw Data
(reads)
Unique Data
(reads) UR-21% UR-18% UR-13% UR-X% UR-Y%
1 92H13 46XX 100 1 387 306 531 327 1.26909 2.91948 3.68963 4.22414 0.00320
2 08H9 46XX 100 1 649 958 622 928 1.26638 2.90997 3.64248 4.22633 0.00385
3 09H10 46XY 100 1 474 317 552 990 1.29496 3.05087 3.91725 2.16279 0.12586
4 10H11 46XY 100 1 501 313 577 494 1.29664 2.98046 3.74255 2.12764 0.12295
5 11H12 46XX 100 1 341 688 514 366 1.26525 2.96754 3.68026 4.18671 0.00447
6 12H14 46XY 100 1 315 342 502 804 1.26968 3.02663 3.77026 2.15392 0.11913
7 13H15 46XX 100 1 520 307 589 707 1.26164 2.93281 3.70743 4.17665 0.00407
8 15H18 46XY 100 1 548 855 589 173 1.27874 3.07974 3.94434 2.16982 0.12560
9 17HCGY 46XY 100 749 354 309 033 1.27818 3.04466 3.87758 2.12275 0.12264
10 19H2 46XY 100 1 929 900 744 124 1.30932 3.08860 3.90929 2.21683 0.12699
11 21H4 46XX 100 3 285 106 1 244 513 1.26613 2.97819 3.82873 4.29276 0.00410
12 25H9 46XY 100 1 575,322 667 903 1.32747 3.00182 3.86819 2.16540 0.12929
13 27H1 46XX 100 947 196 377 647 1.27924 2.91754 3.67009 4.09139 0.02304
14 31H6 46XY 100 1 248 950 476 205 1.29776 2.98863 3.57304 2.05458 0.13776
15 32H7 46XY 100 693 356 268 692 1.34987 2.88137 3.58328 2.01383 0.12840
16 33H8 46XY 100 929 156 371 080 1.31239 2.99262 3.70971 2.05805 0.13825
17 34H9 46XY 100 1 647 104 646 180 1.30010 2.94190 3.62840 2.01244 0.13263
18 40H6 46XX 100 728 707 278 944 1.26190 2.88158 3.41323 4.01586 0.01972
19 42H8 46XY 100 2 021 819 829 302 1.29856 3.00795 3.82840 2.08272 0.13578
20 43H9 46XX 100 685 181 270 538 1.27967 2.90236 3.52557 4.06486 0.02735
21 44H10 46XY 100 993 450 400 726 1.30688 3.00180 3.72499 2.09894 0.13550
22 45H11 46XY 100 636 527 250 931 1.30315 2.93308 3.64762 2.08464 0.13709
23 46H12 46XY 100 1 010 133 399 849 1.30249 2.96512 3.72216 2.09129 0.14480
24 47H13 46XY 100 764 726 301 493 1.28494 2.95828 3.58284 2.08827 0.13466
25 48H1 46XY 100 3 003 505 1 149 789 1.29728 3.03621 3.86358 2.27746 0.11976
26 54H7 46XY 100 1 561 427 589 196 1.29923 3.03974 3.85305 2.12900 0.12424
27 56H9 46XX 100 2 322 635 885 707 1.27119 2.98022 3.78613 4.21618 0.00339
28 57H10 46XX 100 1 278 926 512 310 1.29219 2.89961 3.57791 4.06414 0.02264
29 60H14 46XY 100 1 618 924 616 422 1.26456 3.06495 3.95038 2.13555 0.12475
30 62H16 46XY 100 661 358 263 458 1.30875 2.89420 3.73532 2.17530 0.12791
31 61HWMH 47XX+21 100 833 041 340 693 1.85651 2.98157 3.71009 4.05644 0.01967
32 72HT21 47XY+21 100 766 103 311 852 1.93585 3.01072 3.82617 2.13627 0.12955
33 74H3 47XX+21 100 1 127 241 458 743 1.91087 2.81705 3.54033 4.03080 0.02180
34 81HWMH 47XX+21 100 650 242 273 303 1.73434 2.77714 3.39257 3.96812 0.02378
35 02H2 47XY+18 90 1 091 649 429 544 1.28206 4.39862 3.64852 2.05544 0.12828
36 06H7 47XY+18 100 1 851 667 706 651 1.26689 4.54298 3.71881 2.10174 0.12198
37 82HCXP 47XY+18 100 503 179 204 295 1.27707 4.42742 3.78815 1.99858 0.11601
38 04H4 46XY 100 1 754 104 666 002 1.29819 2.94188 3.67957 2.12507 0.11662
39 05H6 46XX 100 2 434 717 898 966 1.27680 2.90456 3.57889 4.13297 0.00389
40 63H17 46XY 90.8 685 313 275 177 1.30970 2.98680 3.86915 2.04850 0.14064
41 65H4 46XY 100 1 202 799 473 140 1.32244 2.97185 3.70208 2.07402 0.14879
42 66H9 46XX 100 1 623 201 617 337 1.27888 2.96166 3.83680 4.27724 0.00340
43 67H10 46XX 100 811 894 327 382 1.28443 2.85660 3.64566 4.10071 0.02474
44 68H11 46XY 100 6 381 643 2 455 268 1.29619 3.07979 3.96616 2.15150 0.12931
45 69H12 46XX 100 955 289 384 784 1.28384 2.93281 3.62723 4.14050 0.02339
46 70H13 46XX 100 833 449 328 863 1.25554 2.91215 3.66147 4.13212 0.02037
47 71H14 46XX 100 1 321 322 523 536 1.29943 2.87430 3.56537 4.04327 0.02636
48 73H2 46XY 100 705 325 277 705 1.32443 2.94017 3.72230 2.07342 0.12639
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Subject Enrollment and Sample Recruitment
The study was approved by the Institutional Review Board of
Beijing Obstetrics and Gynecology hospital of the Capital Medical
University. Informed consent was obtained from each participant.
A total of 32 pregnant women at a high risk of Down’s
syndrome were recruited as test cases from the Beijing Obstetrics
and Gynecology hospital during the period of January to May
2010. Amniocentesis was applied at 19,22th gestational week and
standard G-band karyotyping analysis was performed. Another 30
euploid AF samples (20 with male fetus and 10 with female fetus)
were included as normal control at the same hospital. To validate
the sensitivity of analysis method for detection of microdeletion/
microduplication, 5 chorionic villus sampling (CVS) samples
validated by karyotyping and arrayCGH were recruited from
the Prenatal Genetic Diagnosis Centre (PGDC) at Department of
Obstetrics & Gynecology, Chinese University of Hong Kong.
Sample Preparation and Sequencing
Genomic DNA was extracted from uncultured AF samples with
Micro DNA Kit (Tiangen) and quantified with the Quant-iT
dsDNA HS Assay Kit (Invitrogen). 100 ng genomic DNA from
each sample was sheared into small fragments ranged from 100 to
400 bp with Bioruptor (Diagenode). After end-repair, ‘‘A’’-
overhanging and adapter-ligation, DNA fragments of 300 bp
(625 bp) in length were selected by 2% agarose gel electrophoresis
and underwent 12 cycles of PCR with multiplex primers. PCR
products were purified by Agencourt AMPure Kit (Beckman). Size
distribution of the library was detected by Agilent Bioanalyzer
DNA 1000 kit (Agilent Technologies) and the concentration was
measured by quantitative PCR (qPCR). Libraries with different
index tags were mixed in equal moles into a pool and sequenced
with single-end 36 cycle multiplex sequencing on Illumina GAIIx
platform.
For the 5 DNA samples from CVS tissues, sequencing libraries
with the insert size of 500 bp (625 bp) were prepared. Paired-end
100 cycle multiplex sequencing was performed on Illumina HiSeq
2000.
Bioinformatics analysis
z-score for detection of fetal aneuploidy. 35-bp single-end
reads from 62 AF samples (30 normal controls and 32 test cases)
were aligned against repeat-masked human genome build 36
(hg18) by ELAND. Unique reads (UR), which can be mapped to
reference genome sequence without any mismatches or alternative
Sample
No.
Labrary
No.
Fetal
Karyotype
DNA Amount
(ng)
Raw Data
(reads)
Unique Data
(reads) UR-21% UR-18% UR-13% UR-X% UR-Y%
49 77H8 46XX 100 664 485 271 294 1.28422 2.95805 3.74686 4.10035 0.02101
50 83HSHD 46XX 100 551 560 223 988 1.26480 2.93632 3.66657 4.01227 0.02411
51 07H8 46XY 100 1 383 844 525 106 1.28203 3.06243 3.92035 2.23364 0.12950
52 94HLCH 46XY 100 888 892 509 386 1.29097 3.02639 3.87113 2.17399 0.11661
53 95HSCJ 46XX 100 863 603 498 346 1.26719 2.93932 3.74920 4.13408 0.00301
54 96HLLR 45XO 100 880 178 508 298 1.29727 3.02775 3.67776 2.11766 0.00315
55 97HHH 45XO 100 984 935 565 960 1.29161 2.99420 3.87572 2.17719 0.00166
56 98HMCM 47XX+21 100 525 892 303 307 1.89610 2.89344 3.47536 4.10475 0.00396
57 99HZQL 46XX 100 898 477 518 330 1.29705 2.98664 3.77655 4.19713 0.00251
58 118AXCR 46XX 99 1 132 088 440 245 1.27406 3.04603 3.82810 2.14335 0.12402
59 121ASSH 47XY+21 100 1 045 028 394 985 1.93628 3.02847 3.72698 2.07983 0.12557
60 125A22 46XX 100 1 217 046 469 095 1.26350 3.03755 3.79454 4.22857 0.00384
61 126AJYJ 47XY+18 100 1 207 389 471 223 1.22044 4.51952 3.77189 2.11895 0.11948
62 129AGJ 47XX+18 100 1 181 077 449 114 1.25358 4.37083 3.69461 4.20539 0.00178
doi:10.1371/journal.pone.0027835.t001
Table 1. Cont.
Figure 1. UR-X% and UR-Y% of 62 amniotic fluid samples.
doi:10.1371/journal.pone.0027835.g001
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PLoS ONE | www.plosone.org 4 February 2012 | Volume 7 | Issue 2 | e27835Figure 2. z-scores of 62 AF samples for chromosome 21,18 and X determined by MPS. Broken lines indicate the z score cut-off value of 63
for trisomy 21 and trisomy 18. All 11 trisomy cases have a z-score value greater than 3 and the 2 cases of Tuner syndrome have a z-score value less
than minus 3.
doi:10.1371/journal.pone.0027835.g002
Figure 3. The normalized UR% value per chromosome between different samples. 11 trisomy samples have a normalized UR% value of 1.5
and 2 cases of 45 XO have a normalized UR% value of 0.5.
doi:10.1371/journal.pone.0027835.g003
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(UR%) of chromosome N (UR-N%, N denotes chromosome
number) can be used as an indicator of fetal trisomy for autosomes.
To satisfy central-limit theorem, 30 euploid samples were used as
normal controls. The z-score of chromosome N (N stands for
chromosome numbers) is calculated as,
zscore chrN~
UR N%mean(UR N% referencecontrols)
SD(UR N% referencecontrols)
For autosomes, considering about the type I error rate (a) of 0.01,
3 was set as a cut-off value to determine the fetal trisomy.
SegSeq algorithm for detection of microdeletion/
microduplication. We mapped the Illumina reads to the
reference sequence of human genome (HG18, NCBI 36.3) by
Short Oligonucleotide Analysis Package aligner (SOAP2) (http://
soap.genomics.org.cn/) [12] with parameter about total allowed
mismatches (-v 5), seed length (-s 40), minimal aligning length (-l
40) and insert DNA size enabled. Only unique reads were
remained in following CNV analysis.
For the CNV detection, we employed a MATLAB packet,
SegSeq (http://www.broadinstitute.org/cgi-bin/cancer/publica-
tions/pub_paper.cgi?mode=view&paper_id=182) [13], with
YH Illumina reads [14] as reference control. Segments with copy
ratio, calculated by SegSeq, less than 0.75 or greater than 1.25
were reported as variations. CNVs on critical regions of identified
diseases would be an important signal for clinical screening/
diagnose.
CNV Detection by arrayCGH and SNP typing
array. Genomic chromosomal copy number variants (CNVs)
were detected using a targeted high resolution 44 K oligonucleotide
arrayspecificallyconstructedforprenatalscreeningwiththeintention
of targeting common trisomic aneuploidies and most known
microdeletion and microduplication syndromes. This Fetal DNA
chip included telomeric and pericentromeric regions, examining the
genome to a resolution of 100 kb (http://www.fetalmedicine.hk/en/
Fetal_DNA_Chip.asp) [15]. The Fetal DNA chip is specially (http://
www.fetalmedicine.hk/en/Fetal_DNA_chip/Appendix_I.pdf) with
most of the known common non-pathogenic CNVs regions
removed. This chip provides a means to detect chromosomal
aberrations with resolution of ,100 Kb across the genome. The
quality of the array was analysed using Agilent DNA analytics
software and cases where the Derivative Log Ratio spread of the
array was .0.25 were excluded from further data analysis. Data
reporting variations in copy number were released after excluding
known non-pathogenic chromosome copy number variants that have
been listed at the Database of Genomic Variants.
To ascertain the accuracy of MSP-based CNV detection
method, two CVS samples were analyzed with HumanOmni2.5-
Quad Bead Chip according to Illumina manufacturer’s protocol
and CNV partition plug-in software was employed for DNA copy
number analysis.
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